Cantel Medical Corp subsidiary Mar Cor Purification is expanding its water purification and filtration operations with the purchase of Siemens Water Technologies’ hemodialysis water business unit.
With about 600 dialysis customers in the US and Canada and 2012 revenue of approximately US$9 million, the acquisition significantly expands Mar Cor Purification’s North American footprint.
Curtis Weitnauer, president and CEO of Mar Cor Purification, said: “The acquisition of the Siemens hemodialysis water customer base enables Mar Cor to realise increased efficiencies from our existing field service operations while also expanding our footprint into new geographies. With this geographic expansion, Mar Cor will further improve its ability to service its large national customers. We look forward to continuing to provide our unique dialysis products and services to our new and existing customers.”
“This acquisition strengthens our position as a leading provider of water purification products and services to the dialysis industry,” said Cantel Medical president and CEO Andrew Krakauer. “We remain confident that our water purification and filtration segment will continue to demonstrate industry leading performance.”
